The present invention relates to dihydroimidazoisoquinolines and derivatives thereof, the use of the compounds as phosphodiesterase 10 (PDE10) inhibitors for the treatment of PDE10-modulated disorders, to pharmaceutical compositions comprising the compounds.
本发明涉及二
氢咪唑异喹啉及其衍
生物,所述化合物作为
磷酸二酯酶10(PDE10)
抑制剂用于治疗PDE10调节的疾病,以及包含该化合物的药物组合物。